Steven M. Goldman, Director at Dova Pharmaceuticals, Inc. (DOVA), bought 5,000 shares at $30.22 ($151K) on 2018-06-21, disclosed to the SEC on 2018-06-25.
Open-market purchase of $151k DOVA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| DOVA | BUY | 2017-08-17 | $897K | — | Filing → |
| CNOB | BUY | 2014-02-06 | $111K | — | Filing → |
| CNOB | BUY | 2014-02-04 | $46K | — | Filing → |